Monimus Capital Management’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-364,306
Closed -$375K 52
2024
Q4
$375K Buy
+364,306
New +$375K 0.35% 45